Literature DB >> 22510462

Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies.

Brian J Miller1, Nickolas Culpepper, Mark H Rapaport, Peter Buckley.   

Abstract

A confluence of evidence supports an association between prenatal inflammation and risk of schizophrenia. Outside of studies of prenatal infections and risk of schizophrenia, other relevant human studies of prenatal inflammation and neurodevelopment in schizophrenia have not been reviewed. In this paper, we review human studies of 1) prenatal inflammation and risk of schizophrenia, 2) inflammation as a potential common mediator of several prenatal risk factors for schizophrenia other than prenatal infections, 3) prenatal inflammation and immune function, neurocognition, brain morphology, and gene expression in adult offspring with schizophrenia, and 4) gene by environment and gene by gene interactions relevant to these associations. We suggest future areas for human studies research based on existing findings.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22510462     DOI: 10.1016/j.pnpbp.2012.03.010

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  34 in total

1.  Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia.

Authors:  Hui-Min Fan; Xin-Yang Sun; Wei Niu; Lin Zhao; Qiao-Li Zhang; Wan-Shuai Li; Ai-Fang Zhong; Li-Yi Zhang; Jim Lu
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

Review 2.  Inflammation and schizophrenia.

Authors:  Brian Kirkpatrick; Brian J Miller
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

3.  Effects of early trauma on psychosis development in clinical high-risk individuals and stability of trauma assessment across studies: a review.

Authors:  Samantha L Redman; Cheryl M Corcoran; David Kimhy; Dolores Malaspina
Journal:  Arch Psychol (Chic)       Date:  2017-12-18

4.  Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.

Authors:  Vishwajit L Nimgaonkar; Faith Dickerson; Jennie G Pouget; Kodavali Chowdari; Colm O'Dushlaine; Joel Wood; Lambertus Klei; Bernie Devlin; Robert Yolken
Journal:  Psychiatry Res       Date:  2017-12-21       Impact factor: 3.222

5.  A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.

Authors:  Brenda Vincenzi; Shannon Stock; Christina P C Borba; Sarah M Cleary; Claire E Oppenheim; Liana J Petruzzi; Xiaoduo Fan; Paul M Copeland; Oliver Freudenreich; Corinne Cather; David C Henderson
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

6.  Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children.

Authors:  Whitney J Cowell; David C Bellinger; Robert O Wright; Rosalind J Wright
Journal:  Brain Behav Immun       Date:  2019-05-31       Impact factor: 7.217

7.  Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Jennifer Schroeder; Emily Katsafanas; Lucy Schweinfurth; Christina Savage; Sunil Khushalani; Robert Yolken
Journal:  Schizophr Bull       Date:  2015-08-19       Impact factor: 9.306

8.  Markers of inflammation in schizophrenia: association vs. causation.

Authors:  Peter Manu; Christoph U Correll; Martien Wampers; Alex J Mitchell; Michel Probst; Davy Vancampfort; Marc De Hert
Journal:  World Psychiatry       Date:  2014-06       Impact factor: 49.548

9.  Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex.

Authors:  Marie Anaïs Labouesse; Erbo Dong; Dennis Robert Grayson; Alessandro Guidotti; Urs Meyer
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

10.  Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.

Authors:  V M Doenni; J M Gray; C M Song; S Patel; M N Hill; Q J Pittman
Journal:  Brain Behav Immun       Date:  2016-07-21       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.